Squeeze Report — September 15, 2026
Short interest is elevated across the tape, but the borrow market is telling a different story: fees are uniformly cheap and shares are available, meaning today's squeeze candidates are catalyst bets, not structural traps. The notable exception is IBRX, where short interest exceeds the entire float, yet a going-concern warning and active ATM keep it a lottery ticket.
Today's top short-squeeze candidates
- #1IRDOpus Genetics, Inc. Common Sto80
31% of float sold short · 12.4 days to cover · +65% over 20 days
SI 31%DTC 12.4$5.97+65% 20dHealthcare - #2VERAVera Therapeutics, Inc. Class80
Pulled-forward ORIGIN eGFR data and a November TRUTAKNA call are the real catalysts, not the 34% short interest.
SI 34%DTC 10.8$34.05+8% 20dHealthcare - #3GLUEMonte Rosa Therapeutics, Inc.78
30% of float sold short · 16.6 days to cover · -10% over 20 days
SI 30%DTC 16.6$13.90-10% 20dHealthcare - #4NEONeoGenomics, Inc. Common Stock77
68% of float sold short · 9.0 days to cover · +15% over 20 days
SI 68%DTC 9.0$18.41+15% 20dHealthcare - #5GRPNGroupon, Inc. Common Stock76
59% of float sold short · 11.3 days to cover · -11% over 20 days
SI 59%DTC 11.3$19.11-11% 20dCommunication Services - #6XXITwenty One Capital, Inc.75
63% of float sold short · 3.8 days to cover · +21% over 20 days
SI 63%DTC 3.8$5.79+21% 20dFinancial Services - #7TDCTERADATA CORPORATION75
BlackRock's new 17.4% stake and Microsoft integration face off against already-declining short interest and insider selling.
SI 18%DTC 7.8$29.37+6% 20dTechnology - #8PHATPhathom Pharmaceuticals, Inc.75
88% revenue growth and a Q4 EoE readout are real, but shorts already reduced 8% and IV shows no urgency.
SI 17%DTC 11.0$8.68-9% 20dHealthcare - #9DXCDXC Technology Company75
A $664M IRS ruling looms and revenue is declining; the 17% short interest is rational, not crowded.
SI 17%DTC 11.1$12.12+12% 20dTechnology - #10SRPTSarepta Therapeutics, Inc. Com74
26% of float sold short · 8.5 days to cover · +16% over 20 days
SI 26%DTC 8.5$20.92+16% 20dHealthcare - #11PRGOPERRIGO COMPANY PLC74
16% of float sold short · 9.0 days to cover · +5% over 20 days
SI 16%DTC 9.0$13.65+5% 20dHealthcare - #12TGTXTG Therapeutics, Inc. Common S74
22% of float sold short · 15.9 days to cover · +11% over 20 days
SI 22%DTC 15.9$54.00+11% 20dHealthcare - #13PBIPitney Bowes Inc.74
12% of float sold short · 12.9 days to cover · +6% over 20 days
SI 12%DTC 12.9$17.33+6% 20dIndustrials - #14MMEDMiniMed Group, Inc. Common Sto74
29% of float sold short · 5.8 days to cover · +9% over 20 days
SI 29%DTC 5.8$21.97+9% 20dHealthcare - #15TVTXTravere Therapeutics, Inc. Com73
FILSPARI's launch has the stock near highs, but zero insider buys and a $602M convert overhang cap the squeeze.
SI 13%DTC 9.6$65.79+6% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →